Saturday, 05/07/2008

Skip navigation

Glossary | Site Map | Text Size: S L |
You are here: Home : Investor Relations

Investor Relations

In June 2006, AstraZeneca (AZ) acquired Cambridge Antibody Technology (CAT), and then acquired MedImmune, Inc. in June 2007.  For investor relations and enquiries please contact AstraZeneca directly.